High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation
- 1 April 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 30 (4), 715-721
- https://doi.org/10.1016/s0168-8278(99)80204-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.Gastroenterology, 1997
- Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantationThe Lancet, 1997
- Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosisThe Lancet, 1996
- Selection of Mutations in the Hepatitis B Virus Polymerase During Therapy of Transplant Recipients With LamivudineHepatology, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Liver transplantation for hepatitis B: The con aspectLiver Transplantation and Surgery, 1995
- Liver Transplantation in European Patients with the Hepatitis B Surface AntigenNew England Journal of Medicine, 1993
- Recurrent hepatitis B in liver allografts: a distinctive form of rapidly developing cirrhosisHistopathology, 1993
- Liver transplantation in HBs antigen (HBsAg) carriers: Prevention of hepatitis B virus (HBV) recurrence by passive immunizationJournal of Hepatology, 1991
- Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitisHepatology, 1991